医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma

摘要BACKGROUND: Increasing evidence indicates that down-regulation of cell adhesion molecule 1 (CADM1) contributes to tumorigenesis in various cancers. The present study was undertaken to investigate the CADM1 expression pattern in human hepatocellular carcinoma (HCC), and to elucidate the mechanism underlying CADM1-mediated tumor suppression. <br> METHODS: CADM1 expression in HCC cell lines was mea-sured by quantitative real-time PCR. The function of CADM1 in the context of tumor suppression in HCC cells was deter-mined using proliferation assays, cell cycle analysis, EdU in-corporation assays,in vitro colony formation analysis, andin vivo tumorigenicity assays. The mechanism by which CADM1 acts as a tumor suppressor gene in HCC was investigated us-ing Western blotting analysis. <br> RESULTS: Downregulation of CADM1 expression is fre-quently detected in both HCC cells and clinical samples. Res-toration of CADM1 expression in HCC cell lines signiifcantly inhibits cell growth and negatively regulates the G1/S transi-tion. CADM1 overexpression can inhibit the tumorigenicity of HCC cells bothin vitro andin vivo. Western blotting analysis revealed that ectopic expression of CADM1 in HCC cells is associated with increased expression of Retinoblastoma (Rb) protein. <br> CONCLUSIONS: Our results showed that suppression of tu-morigenesis by CADM1 may be mediated by the Rb-E2F path-way, involving upregulation of Rb protein levels. This pathway could therefore represent an attractive target for HCC therapy.

更多
广告
提交
  • 浏览0
  • 下载0
国际肝胆胰疾病杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new智医 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷